US Map / New Hampshire
State NH

Clinical Trials in New Hampshire

Recruiting clinical trials with at least one study location in New Hampshire. Data updated daily from ClinicalTrials.gov.

Total Trials
43
Recruiting Now
43
← Back to US Map
Top Conditions in New Hampshire
Advanced Cancer (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)Early Stage Triple-Negative Breast Carcinoma (1)Grade 2 Meningioma (1)Intracranial Meningioma (1)Stroke (1)Thromboses, Intracranial (1)Aneurysm, Brain (1)Metastatic Head and Neck Squamous Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in New Hampshire

How many clinical trials are currently recruiting in New Hampshire?
ClinicalMetric currently tracks 43 actively recruiting clinical trials with at least one location in New Hampshire. The total number of registered studies—including active but not currently enrolling trials—is 43. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Hampshire?
New Hampshire hosts clinical trials across a broad range of medical conditions, including Advanced Cancer, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Hampshire serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Hampshire?
To join a clinical trial in New Hampshire, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Hampshire maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in New Hampshire

NCT05929768 Phase 3
Recruiting
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple N...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
2,400 pts
Location
United States, Mexico, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
View Trial →
NCT06589804 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatme...
Condition
Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment
158 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05064709 N/A
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Condition
Heart Failure
Enrollment
1,500 pts
Location
United States
Sponsor
Impulse Dynamics
View Trial →
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT06455085 N/A
Recruiting
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Condition
Osteoporosis
Enrollment
2,634 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT05139277 N/A
Recruiting
Evaluation of the CONVIVO System
Condition
Glioblastoma
Enrollment
30 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
View Trial →
NCT03851445 Phase 2, Phase 3
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung...
Condition
Previously Treated Non-Small Cell Lung Cancer
Enrollment
10,000 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05775523 N/A
Recruiting
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatro...
Condition
Growth Hormone Deficiency
Enrollment
500 pts
Location
United States
Sponsor
Ascendis Pharma Endocrinology
View Trial →
NCT06309979 N/A
Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
Condition
Idiopathic Short Stature
Enrollment
300 pts
Location
United States
Sponsor
BioMarin Pharmaceutical
View Trial →
NCT04031677 Phase 3
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sa...
Condition
Retroperitoneal Sarcoma
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
European Organisation for Rese
View Trial →
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06362369 Phase 1, Phase 2
Recruiting
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by ...
Condition
Advanced Cancer
Enrollment
126 pts
Location
United States
Sponsor
7 Hills Pharma, LLC
View Trial →
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT04875429 N/A
Recruiting
Zenith® Fenestrated+ Clinical Study
Condition
Aortic Aneurysm, Abdominal
Enrollment
105 pts
Location
United States, United Kingdom
Sponsor
Cook Research Incorporated
View Trial →
NCT02269592 N/A
Recruiting
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events ...
Condition
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Enrollment
10,000 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT06220656 N/A
Recruiting
TRAIL Study: Feasibility and Pilot
Condition
Thyroid Nodule
Enrollment
20 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
View Trial →
NCT05313165 N/A
Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-St...
Condition
Critical Limb Ischemia
Enrollment
100 pts
Location
United States
Sponsor
LimFlow, Inc.
View Trial →
NCT05952557 Phase 3
Recruiting
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2-...
Condition
Breast Cancer, Early Breast Cancer
Enrollment
5,500 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05991453 N/A
Recruiting
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anes...
Condition
Surgery-Complications
Enrollment
13,000 pts
Location
United States
Sponsor
Washington University School o
View Trial →
NCT06429280 N/A
Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
Condition
Amblyopia
Enrollment
500 pts
Location
United States
Sponsor
Luminopia
View Trial →
NCT05405413 Phase 2
Recruiting
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
Condition
Cancer
Enrollment
192 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
View Trial →
NCT06777368 N/A
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failu...
Condition
Aortic Stenosis
Enrollment
225 pts
Location
United States
Sponsor
Medtronic Cardiovascular
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
Page 1 of 2 — 43 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology